These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 21493871)

  • 1. Multilocus association of genetic variants in MLL, CREBBP, EP300, and TOP2A with childhood acute lymphoblastic leukemia in Hispanics from Texas.
    Piwkham D; Gelfond JA; Rerkamnuaychoke B; Pakakasama S; Rebel VI; Pollock BH; Winick NJ; Collier AB; Tomlinson GE; Beuten J
    Cancer Epidemiol Biomarkers Prev; 2011 Jun; 20(6):1204-12. PubMed ID: 21493871
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Novel susceptibility variants at 10p12.31-12.2 for childhood acute lymphoblastic leukemia in ethnically diverse populations.
    Xu H; Yang W; Perez-Andreu V; Devidas M; Fan Y; Cheng C; Pei D; Scheet P; Burchard EG; Eng C; Huntsman S; Torgerson DG; Dean M; Winick NJ; Martin PL; Camitta BM; Bowman WP; Willman CL; Carroll WL; Mullighan CG; Bhojwani D; Hunger SP; Pui CH; Evans WE; Relling MV; Loh ML; Yang JJ
    J Natl Cancer Inst; 2013 May; 105(10):733-42. PubMed ID: 23512250
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Polymorphisms in the MLL breakpoint cluster region (BCR).
    Echlin-Bell DR; Smith LL; Li L; Strissel PL; Strick R; Gupta V; Banerjee J; Larson R; Relling MV; Raimondi SC; Hayashi Y; Taki T; Zeleznik-Le N; Rowley JD
    Hum Genet; 2003 Jul; 113(1):80-91. PubMed ID: 12665971
    [TBL] [Abstract][Full Text] [Related]  

  • 4. An in vivo topoisomerase II cleavage site and a DNase I hypersensitive site colocalize near exon 9 in the MLL breakpoint cluster region.
    Strissel PL; Strick R; Rowley JD; Zeleznik-Le NJ
    Blood; 1998 Nov; 92(10):3793-803. PubMed ID: 9808573
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular analysis of 13 cases of MLL/11q23 secondary acute leukemia and identification of topoisomerase II consensus-binding sequences near the chromosomal breakpoint of a secondary leukemia with the t(4;11).
    Domer PH; Head DR; Renganathan N; Raimondi SC; Yang E; Atlas M
    Leukemia; 1995 Aug; 9(8):1305-12. PubMed ID: 7643617
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Whole-transcriptome sequencing identifies a distinct subtype of acute lymphoblastic leukemia with predominant genomic abnormalities of EP300 and CREBBP.
    Qian M; Zhang H; Kham SK; Liu S; Jiang C; Zhao X; Lu Y; Goodings C; Lin TN; Zhang R; Moriyama T; Yin Z; Li Z; Quah TC; Ariffin H; Tan AM; Shen S; Bhojwani D; Hu S; Chen S; Zheng H; Pui CH; Yeoh AE; Yang JJ
    Genome Res; 2017 Feb; 27(2):185-195. PubMed ID: 27903646
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Low NAD(P)H:quinone oxidoreductase activity is associated with increased risk of leukemia with MLL translocations in infants and children.
    Smith MT; Wang Y; Skibola CF; Slater DJ; Lo Nigro L; Nowell PC; Lange BJ; Felix CA
    Blood; 2002 Dec; 100(13):4590-3. PubMed ID: 12393620
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ARID5B genetic polymorphisms contribute to racial disparities in the incidence and treatment outcome of childhood acute lymphoblastic leukemia.
    Xu H; Cheng C; Devidas M; Pei D; Fan Y; Yang W; Neale G; Scheet P; Burchard EG; Torgerson DG; Eng C; Dean M; Antillon F; Winick NJ; Martin PL; Willman CL; Camitta BM; Reaman GH; Carroll WL; Loh M; Evans WE; Pui CH; Hunger SP; Relling MV; Yang JJ
    J Clin Oncol; 2012 Mar; 30(7):751-7. PubMed ID: 22291082
    [TBL] [Abstract][Full Text] [Related]  

  • 9. All patients with the T(11;16)(q23;p13.3) that involves MLL and CBP have treatment-related hematologic disorders.
    Rowley JD; Reshmi S; Sobulo O; Musvee T; Anastasi J; Raimondi S; Schneider NR; Barredo JC; Cantu ES; Schlegelberger B; Behm F; Doggett NA; Borrow J; Zeleznik-Le N
    Blood; 1997 Jul; 90(2):535-41. PubMed ID: 9226152
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cytogenetics of Hispanic and White children with acute lymphoblastic leukemia in California.
    Aldrich MC; Zhang L; Wiemels JL; Ma X; Loh ML; Metayer C; Selvin S; Feusner J; Smith MT; Buffler PA
    Cancer Epidemiol Biomarkers Prev; 2006 Mar; 15(3):578-81. PubMed ID: 16537719
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ataxia telangiectasia mutated-dependent regulation of topoisomerase II alpha expression and sensitivity to topoisomerase II inhibitor.
    Tamaichi H; Sato M; Porter AC; Shimizu T; Mizutani S; Takagi M
    Cancer Sci; 2013 Feb; 104(2):178-84. PubMed ID: 23163762
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Distribution of 11q23 breakpoints within the MLL breakpoint cluster region in de novo acute leukemia and in treatment-related acute myeloid leukemia: correlation with scaffold attachment regions and topoisomerase II consensus binding sites.
    Broeker PL; Super HG; Thirman MJ; Pomykala H; Yonebayashi Y; Tanabe S; Zeleznik-Le N; Rowley JD
    Blood; 1996 Mar; 87(5):1912-22. PubMed ID: 8634439
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Topoisomerase II and the etiology of chromosomal translocations.
    Felix CA; Kolaris CP; Osheroff N
    DNA Repair (Amst); 2006 Sep; 5(9-10):1093-108. PubMed ID: 16857431
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Analysis of t(9;11) chromosomal breakpoint sequences in childhood acute leukemia: almost identical MLL breakpoints in therapy-related AML after treatment without etoposides.
    Langer T; Metzler M; Reinhardt D; Viehmann S; Borkhardt A; Reichel M; Stanulla M; Schrappe M; Creutzig U; Ritter J; Leis T; Jacobs U; Harbott J; Beck JD; Rascher W; Repp R
    Genes Chromosomes Cancer; 2003 Apr; 36(4):393-401. PubMed ID: 12619163
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Three-way translocation involving MLL, MLLT1, and a novel third partner, NRXN1, in a patient with acute lymphoblastic leukemia and t(2;19;11) (p12;p13.3;q23).
    Lee SG; Park TS; Won SC; Song J; Lee KA; Choi JR; Marschalek R; Meyer C
    Cancer Genet Cytogenet; 2010 Feb; 197(1):32-8. PubMed ID: 20113834
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dietary bioflavonoids induce cleavage in the MLL gene and may contribute to infant leukemia.
    Strick R; Strissel PL; Borgers S; Smith SL; Rowley JD
    Proc Natl Acad Sci U S A; 2000 Apr; 97(9):4790-5. PubMed ID: 10758153
    [TBL] [Abstract][Full Text] [Related]  

  • 17. MLL gene rearrangement, cytogenetic 11q23 abnormalities, and expression of the NG2 molecule in infant acute myeloid leukemia.
    Hilden JM; Smith FO; Frestedt JL; McGlennen R; Howells WB; Sorensen PH; Arthur DC; Woods WG; Buckley J; Bernstein ID; Kersey JH
    Blood; 1997 May; 89(10):3801-5. PubMed ID: 9160687
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The MLL gene and translocations involving chromosomal band 11q23 in acute leukemia.
    De Braekeleer M; Morel F; Le Bris MJ; Herry A; Douet-Guilbert N
    Anticancer Res; 2005; 25(3B):1931-44. PubMed ID: 16158928
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MLL genomic breakpoint distribution within the breakpoint cluster region in de novo leukemia in children.
    Felix CA; Hosler MR; Slater DJ; Parker RI; Masterson M; Whitlock JA; Rebbeck TR; Nowell PC; Lange BJ
    J Pediatr Hematol Oncol; 1998; 20(4):299-308. PubMed ID: 9703001
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Frequencies and prognostic impact of RAS mutations in MLL-rearranged acute lymphoblastic leukemia in infants.
    Driessen EM; van Roon EH; Spijkers-Hagelstein JA; Schneider P; de Lorenzo P; Valsecchi MG; Pieters R; Stam RW
    Haematologica; 2013 Jun; 98(6):937-44. PubMed ID: 23403319
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.